WithdrawnPHASE2, PHASE3NCT00936767

Artemisone for the Treatment of Uncomplicated Falciparum Malaria in Western Cambodia

Studying Malaria

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Oxford
Principal Investigator
Duong Socheat, MD
Cambodia National Malaria Control Programme
Intervention
Artemisone/Mefloquine (AmiM3)(drug)
Eligibility
16 years · All sexes
Timeline
2010 – 2010

Study locations (1)

Collaborators

Mahidol University · Medicines for Malaria Venture

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00936767 on ClinicalTrials.gov

Other trials for Malaria

Additional recruiting or active studies for the same condition.

See all trials for Malaria →

← Back to all trials